Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;47(9):2499-2506.
doi: 10.1002/hed.28154. Epub 2025 Apr 21.

Accurate and Efficient Detection of Nasopharyngeal Carcinoma Using Multi-Dimensional Features of Plasma Cell-Free DNA

Affiliations

Accurate and Efficient Detection of Nasopharyngeal Carcinoma Using Multi-Dimensional Features of Plasma Cell-Free DNA

Song Zhang et al. Head Neck. 2025 Sep.

Abstract

Background: The incidence of Nasopharyngeal carcinoma (NPC) is rising in recent years, especially in some non-developed parts of the world. Hence, cost-efficient means for sensitive detection of NPC are vital.

Methods: We recruited 646 participants, including healthy individuals, patients with benign nasopharyngeal diseases, and NPC patients for plasma cell-free DNA(cfDNA), which underwent low-depth whole-genome sequencing (WGS) to extract multi-dimensional molecular features, including fragmentation pattern, end motif, copy number variation(CNV), and transcription factors(TF). Based on these features, we employed a machine learning algorithm to build prediction models for NPC detection.

Results: We achieved a sensitivity of 95.8% and a specificity of 99.4% to discriminate NPC patients from healthy individuals.

Conclusions: This study can be a proof-of-concept for these multi-dimensional molecular features to be implemented as a noninvasive approach for the detection and even early detection of NPC.

Keywords: cell‐free DNA; copy number variations (CNV); machine learning; nasopharyngeal carcinoma; whole genome sequencing (WGS).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
General workflow of this study.
FIGURE 2
FIGURE 2
Fragmentation profiles of cfDNA samples from different cohorts. Fragmentation profiles of cfDNA samples from healthy cohort, nasopharyngeal benign disease cohort, and NPC cohort. The X‐axis represents 5 Mb bins across the human genome, while the Y‐axis represents the difference to the average ratio of short to long cfDNA fragments for each bin.
FIGURE 3
FIGURE 3
Motif feature of three cohorts on the top 10 selected motifs by proportion. The abscissa represents the motif sequence, and the ordinate represents the proportion of each of the 10 motifs. [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 4
FIGURE 4
CNV profiles of cfDNA samples from different groups. The X‐axis represents 0.5 Mb bins across the human genome, while the Y‐axis represents the CNV log2 ratio values in each bin.
FIGURE 5
FIGURE 5
TFs analysis. The read depth of TFBSs in the healthy cohort (curves in green), nasopharyngeal benign disease cohort (curves in yellow), and NPC cohort (curves in red). [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 6
FIGURE 6
Machine learning models detect NPC patients with high sensitivity and specificity based on cfDNA fragmentation profiles. Green ROC curve represents the prediction model to discriminate NPC patients from healthy individuals. Blue ROC curve represents the prediction model to discriminate NPC patients from non‐cancer individuals. Yellow ROC curve represents the prediction model to discriminate NPC patients from benign nasopharyngeal diseases. [Color figure can be viewed at wileyonlinelibrary.com]

Similar articles

References

    1. Torre L. A., Bray F., Siegel R. L., Ferlay J., Lortet‐Tieulent J., and Jemal A., “Global Cancer Statistics, 2012,” CA: A Cancer Journal for Clinicians 65 (2015): 87–108. - PubMed
    1. Zheng R., Zhang S., Zeng H., et al., “Cancer Incidence and Mortality in China, 2016,” Journal of the National Cancer Center 2, no. 1 (2022): 1–9. - PMC - PubMed
    1. Su Z. Y., Siak P. Y., Lwin Y. Y., and Cheah S. C., “Epidemiology of Nasopharyngeal Carcinoma: Current Insights and Future Outlook,” Cancer Metastasis Reviews 43 (2024): 919–939. - PubMed
    1. Chen Y.‐P., Chan A. T. C., Le Q.‐T., Blanchard P., Sun Y., and Ma J., “Nasopharyngeal Carcinoma,” Lancet 394 (2019): 64–80. - PubMed
    1. Li T., Li F., Guo X., et al., “Anti‐EBV BNLF2b for Mass Screening for Nasopharyngeal Cancer,” New England Journal of Medicine 389, no. 9 (2023): 808–819. - PubMed

LinkOut - more resources